论文部分内容阅读
目的 探讨经尿道前列腺电气化切除术(TUVP)治疗前列腺增生症(BPH)的有效性、安全性和远期效果。方法 312例BPH患者进行TUVP手术。术前以及术后3﹑6﹑12﹑24 m分别进行IPSS﹑QOL评分﹑尿流动力学﹑剩余尿量测定。301例(96 .47%)随访资料完整。结果 术后24月IPSS评分从26.52减少至6.1 (P<0.05);QOL评分也从5.32下降至1 .47 (P<0.05);最大尿流率(Qmax)增加明显,从7.6ml/s增至18.3ml/s(P<0.05);平均尿流率(AFR)从3 .4ml/s增至9.89ml/s;排尿量(VV)较前亦有所增加(P>0.05),尤以排尿等待时间(DT) 缩短,从61s减少至5.2s,剩余尿量(RU)从98.3ml减少至13.4ml(P<0.01)。结论 TUVP是一种易于掌握、出血量少、安全性高的治疗BPH的手术方法,远期疗效肯定。
Objective To investigate the efficacy, safety and long-term efficacy of transurethral electrovaporization of the prostate (TUVP) in the treatment of benign prostatic hyperplasia (BPH). Methods TUVP was performed in 312 BPH patients. IPSS, QOL score, urodynamics and residual urine volume were measured preoperatively and 3, 6, 12, and 24 m after surgery respectively. 301 cases (96.47%) follow-up data is complete. Results The IPSS score decreased from 26.52 to 6.1 (P <0.05) at 24 months postoperatively. The QOL score decreased from 5.32 to 1.47 (P <0.05). The maximum flow rate (Qmax) increased significantly from 7.6ml / s To 18.3ml / s (P <0.05). The mean flow rate of urine (AFR) increased from 3.4ml / s to 9.89ml / s. Urinary output (VV) also increased Urination latency (DT) decreased from 61 s to 5.2 s and residual urine output (RU) decreased from 98.3 ml to 13.4 ml (P <0.01). Conclusion TUVP is a surgical method for the treatment of BPH that is easy to grasp, less bleeding and safe. The long-term curative effect is certain.